Nocopi (NNUP) 10-Q 14 Nov 18 2018 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2018	Nov. 12, 2018
Document And Entity Information
Entity Registrant Name	NOCOPI TECHNOLOGIES INC/MD/
Entity Central Index Key	888,981
Document Type	10-Q
Document Period End Date	Sep. 30, 2018
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		58,616,716
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,018

Statements of Operations

Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenues
Licenses, royalties and fees	$ 175,200	$ 178,200	$ 2,005,700	$ 468,900
Product and other sales	386,200	224,200	854,800	634,500
Total revenues	561,400	402,400	2,860,500	1,103,400
Cost of revenues
Licenses, royalties and fees	35,100	23,300	84,300	71,100
Product and other sales	137,900	82,300	323,500	248,600
Total cost of revenues	173,000	105,600	407,800	319,700
Gross profit	388,400	296,800	2,452,700	783,700
Operating expenses
Research and development	38,100	36,300	111,300	109,200
Sales and marketing	74,600	67,200	313,200	187,900
General and administrative	73,400	80,400	277,600	240,000
Total operating expenses	186,100	183,900	702,100	537,100
Net income from operations	202,300	112,900	1,750,600	246,600
Other income (expenses)
Interest income	700	200	1,400	200
Interest expense, bank charges and accretion of interest	(2,600)	(3,300)	(8,300)	(22,600)
Total other income (expenses)	(1,900)	(3,100)	(6,900)	(22,400)
Net income before income taxes	200,400	109,800	1,743,700	224,200
Income taxes	199,300		199,300
Net income	$ 1,100	$ 109,800	$ 1,544,400	$ 224,200
Basic and diluted net income per common share	$ 0	$ 0	$ .03	$ 0
Weighted average common shares outstanding
Basic	58,616,716	58,599,016	58,616,716	58,599,016
Diluted	59,012,626	58,896,464	58,977,284	58,891,635

Balance Sheets

Balance Sheets - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Current assets
Cash	$ 286,300	$ 360,400
Accounts receivable less $5,000 allowance for doubtful accounts	600,100	292,100
Inventory	130,700	110,600
Prepaid and other	43,300	35,300
Total current assets	1,060,400	798,400
Fixed assets
Leasehold improvements	19,700	19,700
Furniture, fixtures and equipment	185,400	184,900
Fixed assets, gross	205,100	204,600
Less: accumulated depreciation and amortization	195,800	190,500
Total fixed assets	9,300	14,100
Other assets
Long-term receivable	1,423,800
Total assets	2,493,500	812,500
Current liabilities
Convertible debentures	128,300	128,300
Accounts payable	23,300	4,900
Accrued expenses	187,300	364,700
Income taxes	93,300
Deferred revenue		99,400
Total current liabilities	432,200	597,300
Other liabilities
Accrued expenses, non-current	99,600
Deferred income taxes	106,000
Total other liabilities	205,600
Stockholders' equity
Common stock, $0.01 par value Authorized - 75,000,000 shares Issued and outstanding - 58,616,716 shares	586,200	586,200
Paid-in capital	12,440,000	12,440,000
Accumulated deficit	(11,170,500)	(12,811,000)
Total stockholders' equity	1,855,700	215,200
Total liabilities and stockholders' equity	$ 2,493,500	$ 812,500

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 5,000	$ 5,000
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	58,616,716	58,616,716
Common stock, shares outstanding	58,616,716	58,616,716

Statements of Cash Flows

Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Operating Activities
Net income	$ 1,544,400	$ 224,200
Adjustments to reconcile net income to net cash provided by (used in) operating activities
Depreciation and amortization	5,300	5,400
Deferred income taxes	106,000
Accretion of interest - convertible debentures		13,200
Non-current assets and liabilities, net	(1,324,200)
Cumulative effect of accounting change	96,100
Net income adjusted for non-cash operating activities	427,600	242,800
(Increase) decrease in assets
Accounts receivable	(308,000)	45,500
Inventory	(20,100)	(40,900)
Prepaid and other	(8,000)	8,100
Increase (decrease) in liabilities
Accounts payable and accrued expenses	(159,000)	(52,700)
Income taxes	93,300
Deferred revenue	(99,400)	(24,200)
Total increase in operating capital	(501,200)	(64,200)
Net cash provided by (used in) operating activities	(73,600)	178,600
Investing Activities
Additions to fixed assets	(500)	(4,900)
Net cash used in investing activities	(500)	(4,900)
Financing Activities
Repayment of demand loan		(10,000)
Net cash used in financing activities		(10,000)
Increase (decrease) in cash	(74,100)	163,700
Cash at beginning of year	360,400	199,100
Cash at end of period	$ 286,300	$ 362,800

Financial Statements

Financial Statements	9 Months Ended
	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Financial Statements	Note 1. Financial Statements The accompanying unaudited condensed financial statements have been prepared by Nocopi Technologies, Inc. (the “Company”). These statements include all adjustments (consisting only of normal recurring adjustments) which management believes necessary for a fair presentation of the statements and have been prepared on a consistent basis using the accounting policies described in the summary of Accounting Policies included in our Company's 2017 Annual Report on Form 10-K. Certain financial information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although our Company believes that the accompanying disclosures are adequate to make the information presented not misleading. The Notes to Financial Statements included in the 2017 Annual Report on Form 10-K should be read in conjunction with the accompanying interim financial statements. The interim operating results for the three months and nine months ended September 30, 2018 may not be necessarily indicative of the operating results expected for the full year. Our Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 220 in reporting comprehensive income. Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income. Since our Company has no items of other comprehensive income, comprehensive income is equal to net income.

Revenues

Revenues	9 Months Ended
	Sep. 30, 2018
Revenue from Contract with Customer [Abstract]
Revenues	Note 2. Revenues On January 1, 2018, our Company adopted ASU 214-09, Revenue from Contracts with Customers Revenue Recognition Our Company recorded a decrease to the opening balance of the accumulated deficit of $96,100 and a corresponding charge to deferred revenue as of January 1, 2018 due to the cumulative impact of the adoption of Topic 606. The disclosure of disaggregated revenue is disclosed in Note 9. The adoption of the new guidance affected our recognition of revenue from licenses and royalties. Under our previous accounting practice, we recognized revenue from licenses and royalties on a straight-line basis over the term of the related license agreement. As a result of our adoption of the new guidance, we will recognize revenue from licensees and royalties at a point in time when the term begins. During the second quarter of 2018, we negotiated an amendment to a license agreement with a licensee that, in addition to expanding the technologies that the licensee is permitted to market, provides for a four year extension to the license agreement that contains guaranteed royalties payable in installments over the term of the amendment to the license agreement. Since the performance obligation is to grant the license for the use of certain patented ink technology as it exists at the time that it is granted, the promise to grant the license is a performance obligation satisfied at a point in time in accordance with Topic 606. The change in accumulated deficit on our Balance Sheet at September 30, 2018, including the aggregate impact of the change in accounting principles which was effective on January 1, 2018, was as follows: Accumulated deficit – January 1, 2018 $ (12,811,000 ) Net earnings 1,544,400 Cumulative effect of accounting change at January 1, 2018 96,100 Accumulated deficit – September 30, 2018 $ (11,170,500 )

Stock Based Compensation

Stock Based Compensation	9 Months Ended
	Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Based Compensation	Note 3. Stock Based Compensation Our Company follows FASB ASC 718, Compensation – Stock Compensation

Convertible Debentures

Convertible Debentures	9 Months Ended
	Sep. 30, 2018
Convertible Debt [Abstract]
Convertible Debentures	Note 4. Convertible Debentures At September 30, 2018, our Company had convertible debentures totaling $128,300 outstanding, which are due during the third quarter of 2019. The convertible debentures bear interest at 7%. At the option of the lender, the debentures and accrued interest are convertible in whole or part into common stock of our Company at $0.025 per share. During the third quarter of 2018, our Company’s Board of Directors approved and the holders of all $128,300 of convertible debentures agreed to extend the maturity dates of those convertible debentures for one year to the third quarter of 2019 with no change in the terms or conditions of the debentures. During the first quarter of 2017, our Company’s Board of Directors approved and the holders of $33,300 of convertible debentures that had matured during the third quarter of 2016, one of which is held by a Director of our Company, accepted an offer of extension whereby the maturity dates of the convertible debentures are extended for two years and the conversion rate of the debentures and accrued interest into Common Stock of our Company is reduced from $0.05 to $0.025. In accordance with FASB ASC 470, this modification of the convertible debentures was recorded as a debt discount to the notes payable of approximately $13,200 with an offsetting credit to additional-paid in capital. In the three months ended March 31, 2017, the entire $13,200 was accreted through interest expense. Our Company also granted warrants in earlier periods to purchase 691,365 shares of our Company’s common stock at $0.02 per share to the holders of the debentures. The warrants are exercisable two years after issuance and expire seven years after issuance. The fair value of the warrants was determined using the Black-Scholes pricing model. The relative fair value of the warrants was recorded as a discount to the notes payable with an offsetting credit to additional paid-in capital since our Company determined that the warrants were an equity instrument in accordance with FASB ASC 815. The debt discount related to the warrant issuances has been accreted through interest expense over the term of the notes payable. The fair value of the warrants was determined using the Black-Scholes pricing model. The relative fair value of the warrants was recorded as a discount to the notes payable with an offsetting credit to additional paid-in capital since our Company determined that the warrants were an equity instrument in accordance with FASB ASC 815. The debt discount related to the warrant issuances has been accreted through interest expense over the term of the notes payable. The following table summarizes our Company’s warrant position at September 30, 2018 and December 31, 2017: Weighted Average Number Exercise Exercise of Shares Price Price Outstanding warrants - December 31, 2017 691,365 $ 0.02 $ 0.02 Outstanding warrants - September 30, 2018 691,365 $ 0.02 $ 0.02 Weighted average remaining contractual life (years) 2.08 Exercisable warrants - September 30, 2018 691,365 $ 0.02 $ 0.02 Weighted average remaining contractual life (years) 2.08

Other Income (Expenses)

Other Income (Expenses)	9 Months Ended
	Sep. 30, 2018
Other Income and Expenses [Abstract]
Other Income (Expenses)	Note 5. Other Income (Expenses) Other income (expenses) in the three months and nine months ended September 30, 2018 and September 30, 2017 includes interest on convertible debentures held by nine investors. Also included in other income (expenses) in the three months and nine months ended September 30, 2017 is interest on an unsecured loan from an individual and, in the nine months ended September 30, 2017, accretion of debt discounts related to the extension of the maturity dates of $33,300 of convertible debentures.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2018
Income Tax Disclosure [Abstract]
Income Taxes	Note 6. Income Taxes There is no provision for federal income taxes for the three months and nine months ended September 30, 2018 and September 30, 2017 due to the availability of net operating loss carryforwards. Our Company has established a valuation allowance for the entire amount of benefits resulting from our Company’s net operating loss carryforwards because our Company has determined that the realization of the net deferred tax asset is not assured. The components for state income tax expense resulting from the limitation on the use of net operating losses are: Three months ended Nine months ended September 30, September 30, 2018 2017 2018 2017 Current state taxes $ 93,300 – $ 93,300 – Deferred state taxes 106,000 – 106,000 – $ 199,300 – $ 199,300 – There was no change in unrecognized tax benefits during the period ended September 30, 2018 and there was no accrual for uncertain tax positions as of September 30, 2018. Tax years from 2015 through 2017 remain subject to examination by U.S. federal and state jurisdictions.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2018
Related Party Transactions [Abstract]
Related Party Transactions	Note 7. Related Party Transactions During the nine months ended September 30, 2018, our Company paid $235,400 to Michael A. Feinstein, M.D., our Company’s Chairman of the Board and Chief Executive Officer, representing the balance of previously deferred salary owed to him under an employment agreement with the Company. During the nine months ended September 30, 2017, our Company paid $151,700 to Dr. Feinstein representing a portion of previously deferred salary owed to him under the employment agreement. During the five month period ended May 31, 2018, Dr. Feinstein deferred $35,400 of salary. During the nine month period ended September 30, 2017, Dr. Feinstein deferred $63,800 of salary. In June 2018, the periodic salary payments provided for in Dr. Feinstein’s employment agreement resumed. At September 30, 2018, there was no remaining deferred salary owed to Dr. Feinstein. There was no interest payable on the deferred salary.

Earnings per Share

Earnings per Share	9 Months Ended
	Sep. 30, 2018
Weighted average common shares outstanding
Earnings per Share	Note 8. Earnings per Share In accordance with FASB ASC 260, Earnings per Share

Major Customer and Geographic I

Major Customer and Geographic Information	9 Months Ended
	Sep. 30, 2018
Major Customer and Geographic Information [Abstract]
Major Customer and Geographic Information	Note 9. Major Customer and Geographic Information Our Company’s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of our Company’s total revenues were: Three Months ended September 30, Nine Months ended September 30, 2018 2017 2018 2017 Customer A 49 % 48 % 20 % 43 % Customer B 22 % 27 % 64 % 25 % Customer C 11 % 4 % 6 % 9 % Our Company’s non-affiliate customers whose individual balances amounted to more than 10% of our Company’s net accounts receivable, expressed as a percentage of net accounts receivable, were: September 30, December 31, 2018 2017 Customer A 11 % 14 % Customer B 81 % 47 % Customer C 4 % 15 % Our Company performs ongoing credit evaluations of its customers and generally does not require collateral. Our Company also maintains allowances for potential credit losses. The loss of a major customer could have a material adverse effect on our Company’s business operations and financial condition. Our Company’s revenues by geographic region are as follows: Three Months ended September 30, Nine Months ended September 30, 2018 2017 2018 2017 North America $ 208,400 $ 181,800 $ 2,067,700 $ 493,600 South America – 1,500 1,500 1,500 Europe 100 100 200 300 Asia 352,900 211,600 791,100 585,800 Australia – 7,400 – 22,200 $ 561,400 $ 402,400 $ 2,860,500 $ 1,103,400

Revenues (Tables)

Revenues (Tables)	9 Months Ended
	Sep. 30, 2018
Revenue from Contract with Customer [Abstract]
Change in Accumulated Deficit Balance	The change in accumulated deficit on our Balance Sheet at September 30, 2018, including the aggregate impact of the change in accounting principles which was effective on January 1, 2018, was as follows: Accumulated deficit – January 1, 2018 $ (12,811,000 ) Net earnings 1,544,400 Cumulative effect of accounting change at January 1, 2018 96,100 Accumulated deficit – September 30, 2018 $ (11,170,500 )

Convertible Debentures (Tables)

Convertible Debentures (Tables)	9 Months Ended
	Sep. 30, 2018
Convertible Debt [Abstract]
Schedule of Warrants Outstanding	The following table summarizes our Company’s warrant position at September 30, 2018 and December 31, 2017: Weighted Average Number Exercise Exercise of Shares Price Price Outstanding warrants - December 31, 2017 691,365 $ 0.02 $ 0.02 Outstanding warrants - September 30, 2018 691,365 $ 0.02 $ 0.02 Weighted average remaining contractual life (years) 2.08 Exercisable warrants - September 30, 2018 691,365 $ 0.02 $ 0.02 Weighted average remaining contractual life (years) 2.08

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2018
Income Tax Disclosure [Abstract]
Components for State Income Tax Expense	The components for state income tax expense resulting from the limitation on the use of net operating losses are: Three months ended Nine months ended September 30, September 30, 2018 2017 2018 2017 Current state taxes $ 93,300 – $ 93,300 – Deferred state taxes 106,000 – 106,000 – $ 199,300 – $ 199,300 –

Major Customer and Geographic_2

Major Customer and Geographic Information (Tables)	9 Months Ended
	Sep. 30, 2018
Segment Reporting [Abstract]
Schedule of Revenues from Non-affiliated Customers	Our Company’s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of our Company’s total revenues were: Three Months ended September 30, Nine Months ended September 30, 2018 2017 2018 2017 Customer A 49 % 48 % 20 % 43 % Customer B 22 % 27 % 64 % 25 % Customer C 11 % 4 % 6 % 9 %
Schedule of Non-affiliated Customers with Accounts Receivable More Than 10%	Our Company’s non-affiliate customers whose individual balances amounted to more than 10% of our Company’s net accounts receivable, expressed as a percentage of net accounts receivable, were: September 30, December 31, 2018 2017 Customer A 11 % 14 % Customer B 81 % 47 % Customer C 4 % 15 %
Schedule of Revenue by Geographic Region	Our Company’s revenues by geographic region are as follows: Three Months ended September 30, Nine Months ended September 30, 2018 2017 2018 2017 North America $ 208,400 $ 181,800 $ 2,067,700 $ 493,600 South America – 1,500 1,500 1,500 Europe 100 100 200 300 Asia 352,900 211,600 791,100 585,800 Australia – 7,400 – 22,200 $ 561,400 $ 402,400 $ 2,860,500 $ 1,103,400

Revenues (Details)

Revenues (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Long-term receivable	$ 1,423,800		$ 1,423,800
Accrued expenses, non-current	99,600		99,600
Accumulated deficit			(12,811,000)
Net earnings	1,100	$ 109,800	1,544,400	$ 224,200
Cumulative effect of accounting change			96,100
Accumulated deficit	(11,170,500)		(11,170,500)
Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Long-term receivable	1,521,700		1,521,700
Accrued expenses, non-current	$ 106,500		$ 106,500

Stock Based Compensation (Detai

Stock Based Compensation (Details)	Sep. 30, 2018USD ($)
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Unrecognized portion of expense related to stock option grants	$ 0

Convertible Debentures (Narrati

Convertible Debentures (Narrative) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Debt Instrument [Line Items]
Interest expense	$ 2,600	$ 3,300	$ 8,300	$ 22,600
Convertible Debt [Member]
Debt Instrument [Line Items]
Convertible debt amount outstanding	128,300		128,300
Convertible debt due during the third quarter of 2019	$ 128,300		$ 128,300
Debt instrument, interest rate	7.00%		7.00%
Number of shares of common stock that can be purchased through warrants	691,365		691,365
Price per share of warrants	$ 0.02		$ 0.02
Warrant exercisable term			2 years	2 years
Warrant expiration term			7 years	7 years
Convertible Debt [Member] | Price One [Member]
Debt Instrument [Line Items]
Debt instrument, conversion price per share	0.025		$ 0.025
Convertible Debt [Member] | Price Two [Member]
Debt Instrument [Line Items]
Amount of principal that can be converted			$ 33,300
Debt instrument, conversion price per share	$ 0.05		$ 0.05
Debt discount recognized on notes payable	$ 13,200		$ 13,200
Accretion of debt discount recognized as interest expense			$ 13,200

Convertible Debentures (Warrant

Convertible Debentures (Warrants Activity) (Details) - Warrant [Member] - $ / shares	9 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Warrants
Warrants outstanding	691,365	691,365
Exercise price	$ 0.02	$ 0.02
Weighted average exercise price	$ 0.02	0.02
Weighted average remaining contractual life	2 years 29 days
Exercisable	691,365
Exercisable weighted average exercise price	$ 0.02	$ 0.02
Exercisable weighted average remaining contractual life	2 years 29 days

Income Taxes (Details)

Income Taxes (Details) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Income Tax Contingency [Line Items]
Income tax provision
Change in unrecognized tax benefits during the period
Accrual for uncertain tax positions
Minimum [Member]
Income Tax Contingency [Line Items]
Tax years open for examination	2,015
Maximum [Member]
Income Tax Contingency [Line Items]
Tax years open for examination	2,017

Income Taxes (Components for St

Income Taxes (Components for State Income Tax Expense) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Income Tax Disclosure [Abstract]
Current state taxes	$ 93,300		$ 93,300
Deferred state taxes	106,000		106,000
Income tax expense	$ 199,300		$ 199,300

Related Party Transactions (Det

Related Party Transactions (Details) - Related Party [Member] - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Related Party Transaction [Line Items]
Deferred salary paid to related party	$ 235,400	$ 151,700
Portion of salary to related party deferred during period	35,400	$ 63,800
Deferred salary owed to related party	$ 0

Earnings per Share (Details)

Earnings per Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Weighted average common shares outstanding
Number of incremental common shares resulting from the assumed conversion of warrants	395,910	297,448	360,568	292,619

Major Customer and Geographic_3

Major Customer and Geographic Information (Schedule of Revenues from Non-affiliated Customers) (Details) - Revenue [Member]	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Customer A [Member]
Revenue, Major Customer [Line Items]
Risk percentage	49.00%	48.00%	20.00%	43.00%
Customer B [Member]
Revenue, Major Customer [Line Items]
Risk percentage	22.00%	27.00%	64.00%	25.00%
Customer C [Member]
Revenue, Major Customer [Line Items]
Risk percentage	11.00%	4.00%	6.00%	9.00%

Major Customer and Geographic_4

Major Customer and Geographic Information (Schedule of Non-affiliated Customers with Accounts Receivable) (Details) - Accounts Receivable [Member]	9 Months Ended	12 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Customer A [Member]
Concentration Risk [Line Items]
Risk percentage	11.00%	14.00%
Customer B [Member]
Concentration Risk [Line Items]
Risk percentage	81.00%	47.00%
Customer C [Member]
Concentration Risk [Line Items]
Risk percentage	4.00%	15.00%

Major Customer and Geographic_5

Major Customer and Geographic Information (Schedule of Revenue by Geographic Region) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 561,400	$ 402,400	$ 2,860,500	$ 1,103,400
North America [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	208,400	181,800	2,067,700	493,600
South America [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues		1,500	1,500	1,500
Europe [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	100	100	200	300
Asia [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	352,900	211,600	791,100	585,800
Australia [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues		$ 7,400		$ 22,200